These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1575301)

  • 1. Efficacy of 131I ablation following thyroidectomy in patients with invasive follicular thyroid cancer.
    Davis NL; Gordon M; Germann E; McGregor GI; Robins RE
    Am J Surg; 1992 May; 163(5):472-5. PubMed ID: 1575301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
    Mazzaferri EL; Jhiang SM
    Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer.
    Hasbek Z; Turgut B; Kilicli F; Altuntas EE; Yucel B
    Asian Pac J Cancer Prev; 2014; 15(6):2523-7. PubMed ID: 24761858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospective therapy study in differentiated thyroid carcinoma].
    Gemsenjäger E; Heitz P; Martina B
    Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally invasive follicular thyroid cancer: treat as a benign or malignant lesion?
    Robinson A; Schneider D; Sippel R; Chen H
    J Surg Res; 2017 Jan; 207():235-240. PubMed ID: 27979483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of surgery for differentiated thyroid cancer.
    Dackiw AP; Zeiger M
    Surg Clin North Am; 2004 Jun; 84(3):817-32. PubMed ID: 15145237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
    Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
    Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial.
    Schlumberger M; Leboulleux S; Catargi B; Deandreis D; Zerdoud S; Bardet S; Rusu D; Godbert Y; Buffet C; Schvartz C; Vera P; Morel O; Benisvy D; Bournaud C; Toubert ME; Kelly A; Benhamou E; Borget I
    Lancet Diabetes Endocrinol; 2018 Aug; 6(8):618-626. PubMed ID: 29807824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioactive iodine administered for thyroid remnant ablation following recombinant human thyroid stimulating hormone preparation also has an important adjuvant therapy function.
    Tuttle RM; Lopez N; Leboeuf R; Minkowitz SM; Grewal R; Brokhin M; Omry G; Larson S
    Thyroid; 2010 Mar; 20(3):257-63. PubMed ID: 20187781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
    Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
    Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Outcomes of long-term combined treatment in follicular thyroid carcinoma].
    Baranauskas Z; Valuckas KP; Tiskevicius S
    Medicina (Kaunas); 2010; 46(4):268-74. PubMed ID: 20571295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using recombinant human TSH in the management of well-differentiated thyroid cancer: current strategies and future directions.
    Mazzaferri EL; Kloos RT
    Thyroid; 2000 Sep; 10(9):767-78. PubMed ID: 11041454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
    Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
    Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of patients to detect recurrent thyroid carcinoma.
    Grigsby PW; Baglan K; Siegel BA
    Cancer; 1999 Feb; 85(4):945-51. PubMed ID: 10091774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of low-risk differentiated thyroid cancer patients after radioiodine remnant ablation and recombinant human thyroid-stimulating hormone preparation.
    Vianello F; Mazzarotto R; Mian C; Lora O; Saladini G; Servodio O; Basso M; Pennelli G; Pelizzo MR; Sotti G
    Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):162-8. PubMed ID: 21411300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
    Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma.
    Lin JD; Kao PF; Chao TC
    Br J Radiol; 1998 Mar; 71(843):307-13. PubMed ID: 9616241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.